Found 38 matching trials
Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children
PHASE2Primary Objective:
To evaluate for each influenza strain the non-inferiori...
Location
Multiple Locations
Comparison of Flu Vaccine Doses in Children
PHASE1The purpose of this study is to evaluate the possibility that giving an inc...
Location
Emory Children's Center - Pediatric Infectious Diseases
CT18 Infant Influenza Priming Study in Vaccine Naive Infants
PHASE2This study evaluates whether priming influenza naive infants, age six to 23...
Location
Vaccine Evaluation Center, BC Children's Hospital
Safety Study of Seasonal Influenza Vaccine by Jet Injection
PHASE4This research study involves testing of a device that can give injections (...
Location
University of Maryland College Park Health Center
Immunogenicity and Safety of Different Doses of Fluzone® Influenza
PHASE2The purpose of this research study is to find out if giving the smaller dos...
Location
Saint Louis University
Th1 Response to Influenza: Aging and Vaccine Efficacy
PHASE4This research study is being done because influenza (flu) affects many peop...
Location
Eastern Virginia Medical School
Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age
PHASE3The purpose of this study is to evaluate Immunogenicity and Safety of a Hig...
Location
CenExel CNS- Site Number : 8400005
Standard vs High-Dose Trivalent Inactivated Flu Vaccine in Adult Hematopoetic Stem Cell Transplant (HSCT) Recipients
PHASE1Hypothesis 1: The safety profile in adult allogeneic stem cell hematopoieti...
Location
Vanderbilt-Ingram Cancer Center, Clinical Trials Information Program
High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients
PHASE2This randomized phase II studies the side effects of high-dose trivalent in...
Location
University of Alabama
Elderly Influenza Vaccine Immunogenicity Substudy
N/AThe body's immune system (fights infection) is known to decline during the ...
Location
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore